(MedPage Today) — Tirzepatide (Mounjaro) improved glucose control and body mass index (BMI) in children with type 2 diabetes who were inadequately controlled with metformin and basal insulin, the phase III SURPASS-PEDS trial showed.
Among 99…
Source link : https://www.medpagetoday.com/meetingcoverage/easd/117539
Author :
Publish date : 2025-09-18 21:25:00
Copyright for syndicated content belongs to the linked Source.
